Type III collagen formation is significantly associated with risk of outcome in HFpEF patients but loses its significant association with underlying AF

Back

ESC Professional Premium Access

Type III collagen formation is significantly associated with risk of outcome in HFpEF patients but loses its significant association with underlying AF

Session: Chronic heart failure and atrial fibrillation

Topic: Heart Failure with Preserved Ejection Fraction (HFpEF)

Speaker: Ms E. Angeli (Copenhagen, DK)

Event: ESC Congress 2022

Congress Presentation

Add to my library

About the speaker

Ms Elisavet Angeli

University of Copenhagen, Copenhagen (Denmark)

1 presentation

0 follower

6 more presentations in this session

Baseline profile and results of atrial fibrillation ablation in patients with arrhythmia-induced cardiomyopathy

Speaker: Ms T. Gonzalez Ferrero (Santiago de Compostela, ES)

Access

Abstract

Slides

Aggressive combined pharmacotherapy for heart failure reduces new onset atrial fibrillation

Speaker: Doctor M. Tokutome (Fukuoka, JP)

Access

Abstract

Slides

Association of beta blocker use with new-onset heart failure and mortality in atrial fibrillation without pre-existing heart failure: the Fushimi AF registry

Speaker: Doctor M. Iguchi (Kyoto, JP) Doctor M. Akao (Kyoto, JP)

Access

Abstract

Slides

ABC adherence and impact of optimal medical therapy in heart failure patients with atrial fibrillation

Speaker: Doctor N. Bonini (Modena, IT)

Access

Abstract

Slides

Survival among people with heart failure and atrial fibrillation; a population cohort study

Speaker: Doctor N. Jones (Oxford, GB)

Access

Abstract

Slides

Access the full session

Chronic heart failure and atrial fibrillation

Speakers: Ms E. Angeli, Ms T. Gonzalez Ferrero, Doctor M. Tokutome, Doctor M. Iguchi, Doctor M. Akao...

Access

About the event

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources